cbdMD (YCBD) EBITDA: 2016-2025
Historic EBITDA for cbdMD (YCBD) over the last 9 years, with Sep 2025 value amounting to -$685,816.
- cbdMD's EBITDA fell 116.65% to -$685,816 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.2 million, marking a year-over-year increase of 34.77%. This contributed to the annual value of -$2.2 million for FY2025, which is 34.77% up from last year.
- Per cbdMD's latest filing, its EBITDA stood at -$685,816 for Q3 2025, which was up 24.19% from -$904,686 recorded in Q2 2025.
- In the past 5 years, cbdMD's EBITDA registered a high of -$86,272 during Q4 2024, and its lowest value of -$33.1 million during Q2 2022.
- Moreover, its 3-year median value for EBITDA was -$904,686 (2025), whereas its average is -$2.2 million.
- In the last 5 years, cbdMD's EBITDA plummeted by 1,328.74% in 2021 and then surged by 97.92% in 2024.
- Over the past 5 years, cbdMD's EBITDA (Quarterly) stood at -$25.1 million in 2021, then soared by 83.91% to -$4.0 million in 2022, then surged by 73.66% to -$1.1 million in 2023, then skyrocketed by 91.91% to -$86,272 in 2024, then crashed by 116.65% to -$685,816 in 2025.
- Its EBITDA was -$685,816 in Q3 2025, compared to -$904,686 in Q2 2025 and -$485,816 in Q1 2025.